Epilepsia

Article	Citations
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions	359
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions	338
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions	194
The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures	177
The SANTÉ study at 10 years of follow‐up: Effectiveness, safety, and sudden unexpected death in epilepsy	162
The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission	140
Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions	112
International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions	109
International consensus on diagnosis and management of Dravet syndrome	97
Epilepsy and brain network hubs	86
Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta‐analysis	86
Seizure detection using wearable sensors and machine learning: Setting a benchmark	76
Deep brain stimulation targets in epilepsy: Systematic review and meta‐analysis of anterior and centromedian thalamic nuclei and hippocampus	69
Genetic testing for the epilepsies: A systematic review	67
Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: A systematic review and meta‐analysis of outcomes	66
Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy	66
Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials	64
Pilot study of focused ultrasound for drug‐resistant epilepsy	61
Connectome biomarkers of drug‐resistant epilepsy	60
International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: Statements and supporting evidence	60
Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial	59
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress	56
Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial	56
Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial	53
Epilepsy care during the COVID‐19 pandemic	53

Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology	52
Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease	52
Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy	52
International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including febrile infection‐related epilepsy syndrome (FIRES): Summary and clinical tools	51
Cross talk between drug‐resistant epilepsy and the gut microbiome	50
Systematic review of frequency of felt and enacted stigma in epilepsy and determining factors and attitudes toward persons living with epilepsy—Report from the International League Against Epilepsy Ta	48
The global cost of epilepsy: A systematic review and extrapolation	48
Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial	46
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development	46
Neurostimulation in people with drug‐resistant epilepsy: Systematic review and meta‐analysis from the ILAE Surgical Therapies Commission	46
Accurate detection of typical absence seizures in adults and children using a two‐channel electroencephalographic wearable behind the ears	46
The severe epilepsy syndromes of infancy: A population‐based study	45
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study	45
Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial	44
Focal to bilateral tonic–clonic seizures are associated with widespread network abnormality in temporal lobe epilepsy	44
The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?	44
Seizure control, stress, and access to care during the COVID‐19 pandemic in New York City: The patient perspective	43
The worldwide epilepsy treatment gap: A systematic review and recommendations for revised definitions – A report from the ILAE Epidemiology Commission	43
Neonatal presentation of genetic epilepsies: Early differentiation from acute provoked seizures	42
Visually sensitive seizures: An updated review by the Epilepsy Foundation	42
Incidence and prevalence of psychogenic nonepileptic seizures in a Norwegian county: A 10‐year population‐based study	42
Practical considerations in epilepsy neurostimulation	41
Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies	41
COVID‐19 vaccine take‐up rate and safety in adults with epilepsy: Data from a multicenter study in China	40
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat	40
Genes4Epilepsy: An epilepsy gene resource	40
External validation of automated focal cortical dysplasia detection using morphometric analysis	39
Epileptic heart: A clinical syndromic approach	39
Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages	39
First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid	39
Virtual epileptic patient brain modeling: Relationships with seizure onset and surgical outcome	38
ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy	37
Carbon emission savings and short‐term health care impacts from telemedicine: An evaluation in epilepsy	37
Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): A cohort st	37
Temporal lobe epilepsy surgery in children and adults: A multicenter study	37
Astrocyte and glutamate involvement in the pathogenesis of epilepsy in Alzheimer's disease	36
Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events	36
SCN2A‐Developmental and Epileptic Encephalopathies: Challenges to trial‐readiness for non‐seizure outcomes	36
Automated seizure detection with noninvasive wearable devices: A systematic review and meta‐analysis	36
Temporal variability profiling of the default mode across epilepsy subtypes	35
Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice	35
Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters	35
Treatment of seizures in the neonate: Guidelines and consensus‐based recommendations—Special report from the ILAE Task Force on Neonatal Seizures	35
Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging	35
Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective	35
Prevalence and incidence of epilepsy in Latin America and the Caribbean: A systematic review and meta‐analysis of population‐based studies	34
Detection of brain somatic variation in epilepsy‐associated developmental lesions	34
Altered communication dynamics reflect cognitive deficits in temporal lobe epilepsy	34
A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut synd	34
The road to a World Health Organization global action plan on epilepsy and other neurological disorders	33

Noninvasive mobile EEG as a tool for seizure monitoring and management: A systematic review	33
The power of ECG in multimodal patient‐specific seizure monitoring: Added value to an EEG‐based detector using limited channels	33
On seizure semiology	33
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study	33
Twenty‐four‐hour patterns in electrodermal activity recordings of patients with and without epileptic seizures	32
Improving the prediction of epilepsy surgery outcomes using basic scalp EEG findings	32
Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs	31
Design and implementation of electronic health record common data elements for pediatric epilepsy: Foundations for a learning health care system	31
A hypothesis for the role of axon demyelination in seizure generation	31
Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program	31
Introduction to the epilepsy syndrome papers	31
Anterior nucleus of the thalamus seizure detection in ambulatory humans	31
Are AI language models such as ChatGPT ready to improve the care of individuals with epilepsy?	31
Intracranial electroencephalographic biomarker predicts effective responsive neurostimulation for epilepsy prior to treatment	31
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development	31
Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications	30
Value of smartphone videos for diagnosis of seizures: Everyone owns half an epilepsy monitoring unit	30
Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study	30
Early‐life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study	30
Hemispherectomy Outcome Prediction Scale: Development and validation of a seizure freedom prediction tool	30
Signal quality and power spectrum analysis of remote ultra long‐term subcutaneous EEG	29
The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results	29
Adjunctive cenobamate in highly active and ultra‐refractory focal epilepsy: A “real‐world” retrospective study	29
Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug‐resistant epilepsy	29
Perampanel and pregnancy	29
Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open‐label, dose‐finding, phase 2 trial	28
CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures	28
Norwegian population‐based study of long‐term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug‐resistant epilepsy: The NORPulse study	28
Wearable devices for seizure detection: Practical experiences and recommendations from the Wearables for Epilepsy And Research (WEAR) International Study Group	28
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long‐term outcome	28
Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review	28
Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort)	28
The epilepsy–autism spectrum disorder phenotype in the era of molecular genetics and precision therapy	27
Interictal electroencephalographic functional network topology in drug‐resistant and well‐controlled idiopathic generalized epilepsy	27
Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, multinational study	27
Seizures in autoimmune encephalitis—A systematic review and quantitative synthesis	27
Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany	27
A physiologically validated rat model of term birth asphyxia with seizure generation after, not during, brain hypoxia	27
Atypical functional connectome hierarchy impacts cognition in temporal lobe epilepsy	27
Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology	26
Predicting mood decline following temporal lobe epilepsy surgery in adults	26
Disruption of intestinal barrier and endotoxemia after traumatic brain injury: Implications for post‐traumatic epilepsy	26
The role of surgery in the management of Lennox–Gastaut syndrome: A systematic review and meta‐analysis of the clinical evidence	26
Transforming epilepsy research: A systematic review on natural language processing applications	26
Correcting for physiological ripples improves epileptic focus identification and outcome prediction	26
Can we use intraoperative high‐frequency oscillations to guide tumor‐related epilepsy surgery?	26
Systematic analysis and comparison of commercial seizure‐detection software	26
Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality	25
Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study	25
Cycles of self‐reported seizure likelihood correspond to yield of diagnostic epilepsy monitoring	25
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain‐ and loss‐of function variants	25
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes	25
Provoked seizures and status epilepticus in a pediatric population with COVID‐19 disease	25
Multicenter, cross‐sectional study of the costs of illness and cost‐driving factors in adult patients with epilepsy	25
Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program	25
Utility of 18F‐fluorodeoxyglucose positron emission tomography in presurgical evaluation of patients with epilepsy: A multicenter study	24
Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment	24
Accurate identification of EEG recordings with interictal epileptiform discharges using a hybrid approach: Artificial intelligence supervised by human experts	24
Long‐term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update	24
Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis	24
Reasons for not having epilepsy surgery	24
Diagnosing cognitive disorders in older adults with epilepsy	24
Identifying seizure risk factors: A comparison of sleep, weather, and temporal features using a Bayesian forecast	24
Wearable OPM‐MEG: A changing landscape for epilepsy	24
The long‐term efficacy of cannabidiol in the treatment of refractory epilepsy	23
Elevated blood purine levels as a biomarker of seizures and epilepsy	23
Sudden unexpected death in epilepsy in persons younger than 50 years: A retrospective nationwide cohort study in Denmark	23
Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly	23
Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder	23
Establishing criteria for pediatric epilepsy surgery center levels of care: Report from the ILAE Pediatric Epilepsy Surgery Task Force	23
Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy	23
Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials	22
Long‐term seizure outcome during continuous bipolar hippocampal deep brain stimulation in patients with temporal lobe epilepsy with or without mesial temporal sclerosis: An observational, open‐label s	22
Evidence supporting deep brain stimulation of the medial septum in the treatment of temporal lobe epilepsy	22
The epidemiology of epilepsy in older adults: A narrative review by theILAETask Force on Epilepsy in the Elderly	21
Patient‐specific structural connectivity informs outcomes of responsive neurostimulation for temporal lobe epilepsy	21
Neurostimulation in generalized epilepsy: A systematic review and meta‐analysis	21
Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways	21
Systemic administration of ivabradine, a hyperpolarization‐activated cyclic nucleotide‐gated channel inhibitor, blocks spontaneous absence seizures	21
Long‐term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy	21

Cost‐effectiveness of adrenocorticotropic hormone versus oral steroids for infantile spasms	20
Adjunctive everolimus therapy for tuberous sclerosis complex‐associated refractory seizures: Results from the postextension phase of EXIST‐3	20
Association between antiseizure medications and quality of life in epilepsy: A mediation analysis	20
Long‐term efficacy, tolerability, and retention of brivaracetam in epilepsy treatment: A longitudinal multicenter study with up to 5 years of follow‐up	20
Episodic memory network connectivity in temporal lobe epilepsy	20
Reply to the commentary by Ben‐Ari and Delpire: Bumetanide and neonatal seizures: Fiction versus reality	20
Drug resistance in idiopathic generalized epilepsies: Evidence and concepts	20
High‐mobility group box 1 as a predictive biomarker for drug‐resistant epilepsy: A proof‐of‐concept study	20
Comparison of the real‐world effectiveness of vertical versus lateral functional hemispherotomy techniques for pediatric drug‐resistant epilepsy: A post hoc analysis of the HOPS study	20
Assessing seizure burden in pediatric epilepsy using an electronic medical record–based tool through a common data element approach	20
Early onset epilepsy and sudden unexpected death in epilepsy with cardiac arrhythmia in mice carrying the early infantile epileptic encephalopathy 47 gain‐of‐function FHF1(FGF12) missense mutat	20
Tofacitinib treatment for refractory autoimmune encephalitis	20
Missed, mistaken, stalled: Identifying components of delay to diagnosis in epilepsy	20
Prehospital lactate levels in blood as a seizure biomarker: A multi‐center observational study	19
Outcomes of children and adolescents 1 year after being seen in a multidisciplinary psychogenic nonepileptic seizures clinic	19
Seizures and memory impairment induced by patient‐derived anti‐N‐methyl‐D‐aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin‐1 receptor antagonist	19
T cell numbers correlate with neuronal loss rather than with seizure activity in medial temporal lobe epilepsy	19
Automatic detection of interictal ripples on scalp EEG to evaluate the effect and prognosis of ACTH therapy in patients with infantile spasms	19
Risk for infantile spasms after acute symptomatic neonatal seizures	19
Epilepsy with myoclonic‐atonic seizures (Doose syndrome): Clarification of diagnosis and treatment options through a large retrospective multicenter cohort	19
Machine learning for the early prediction of infants with electrographic seizures in neonatal hypoxic‐ischemic encephalopathy	19
Minimum standards for inpatient long‐term video‐electroencephalographic monitoring: A clinical practice guideline of the International League Against Epilepsy and International Federation of Clinical	19
Seizure forecasting using minimally invasive, ultra‐long‐term subcutaneous electroencephalography: Individualized intrapatient models	19
Incidence and risk factors of posttraumatic epilepsy following pediatric traumatic brain injury: A systematic review and meta‐analysis	19
Decoupling of functional and structural language networks in temporal lobe epilepsy	19
Responsive neurostimulation with low‐frequency stimulation	19
A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia	19
Regional brain atrophy and aberrant cortical folding relate to anxiety and depression in patients with traumatic brain injury and psychogenic nonepileptic seizures	19
A national study of epilepsy‐related deaths in Scotland: Trends, mechanisms, and avoidable deaths	19
Cell death of hippocampal CA1 astrocytes during early epileptogenesis	19
Experience and consensus on stimulation of the anterior nucleus of thalamus for epilepsy	18
Gut microbiota modulates seizure susceptibility	18
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo‐controlled clinical trial	18
Rapid administration of undiluted intravenous levetiracetam	18
Economic burden of epilepsy in children: A population‐based matched cohort study in Canada	18
CASPR2‐IgG‐associated autoimmune seizures	18
Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models	18
Relationship between neural responses to stress and mental health symptoms in psychogenic nonepileptic seizures after traumatic brain injury	18
Brain network excitatory/inhibitory imbalance is a biomarker for drug‐naive Rolandic epilepsy: A radiomics strategy	18
Epilepsy centers in China: Current status and ways forward	18
The molecular and phenotypic spectrum of CLCN4‐related epilepsy	17
Folic acid supplementation rescues valproic acid‐induced developmental neurotoxicity and behavioral alterations in zebrafish embryos	17
Social outcome and psychiatric comorbidity of generalized epilepsies – A case‐control study	17
Prolonged epileptic discharges predict seizure recurrence in JME: Insights from prolonged ambulatory EEG	17
Autopsy‐reported cause of death in a population‐based cohort of sudden unexpected death in epilepsy	17
Modeling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable	17
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI):II. Drugs in more advanced clinical dev	17
Effects of early life seizures on coordination of hippocampal–prefrontal networks: Influence of sex and dynamic brain states	17
Deciphering key regulators involved in epilepsy‐induced cardiac damage through whole transcriptome and proteome analysis in a rat model	17
Putative roles for homeostatic plasticity in epileptogenesis	17
Seizure occurrence is linked to multiday cycles in diverse physiological signals	17
Accelerated long‐term forgetting in focal epilepsy: Do interictal spikes during sleep matter?	17
Altered spreading of neuronal avalanches in temporal lobe epilepsy relates to cognitive performance: A resting‐state hdEEG study	17
Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody‐associated disease	17
Excitatory/inhibitory balance in epilepsies and neurodevelopmental disorders: Depolarizing γ‐aminobutyric acid as a common mechanism	17
Serum neurofilament light as biomarker of seizure‐related neuronal injury in status epilepticus	17
Long‐term outcome in a noninvasive rat model of birth asphyxia with neonatal seizures: Cognitive impairment, anxiety, epilepsy, and structural brain alterations	17
Effects of lacosamide and carbamazepine on lipids in a randomized trial	17
Automated detection of absence seizures using a wearable electroencephalographic device: a phase 3 validation study and feasibility of automated behavioral testing	17
Surgical evaluation in children <3 years of age with drug‐resistant epilepsy: Patient characteristics, diagnostic utilization, and potential for treatment delays	17
Spike patterns surrounding sleep and seizures localize the seizure‐onset zone in focal epilepsy	17
Duration of epileptic seizure types: A data‐driven approach	17
Improving prediction of sudden unexpected death in epilepsy: From SUDEP‐7 to SUDEP‐3	17
Perampanel as precision therapy in rare genetic epilepsies	16
Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor	16
Decision‐making in stereotactic epilepsy surgery	16
Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio?	16
Clinical phenotypes within nonconvulsive status epilepticus	16
Psychogenic nonepileptic seizures treated as epileptic seizures in the emergency department	16
Factors affecting breastfeeding in women with epilepsy	16
Epilepsy‐related stigma and attitudes: Systematic review of screening instruments and interventions ‐ Report by the International League Against Epilepsy Task Force on Stigma in Epilepsy	16
Susceptibility to epilepsy after traumatic brain injury is associated with preexistent gut microbiome profile	16
Thalamic oscillatory activity may predict response to deep brain stimulation of the anterior nuclei of the thalamus	16
Clinical utility of intraoperative electrocorticography for epilepsy surgery: A systematic review and meta‐analysis	16
In‐hospital and home‐based long‐term monitoring of focal epilepsy with a wearable electroencephalographic device: Diagnostic yield and user experience	16
Diverse genetic causes of polymicrogyria with epilepsy	16
Gain of function SCN1A disease‐causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication	16
Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials	16
Routine and sleep EEG: Minimum recording standards of the International Federation of Clinical Neurophysiology and the International League Against Epilepsy	15
Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy	15
Prenatal exposure to valproate and risk of congenital malformations—Could we have known earlier?—A population‐based cohort study	15
Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study	15
Magnetic resonance imaging findings and clinical characteristics in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy in a predominantly adult cohort	15
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study	15
COVID‐19 vaccine in patients with Dravet syndrome: Observations and real‐world experiences	15
Acute thalamic damage as a prognostic biomarker for post‐traumatic epileptogenesis	15
Relative entropy is an easy‐to‐use invasive electroencephalographic biomarker of the epileptogenic zone	15
Etiology‐specific response to antiseizure medication in focal epilepsy	15
Musicogenic epilepsy: Expanding the spectrum of glutamic acid decarboxylase 65 neurological autoimmunity	15
High‐frequency oscillations (250–500 Hz) in animal models of Alzheimer's disease and two animal models of epilepsy	15
Deep learning resting state functional magnetic resonance imaging lateralization of temporal lobe epilepsy	15
Cost‐effectiveness analysis of responsive neurostimulation for drug‐resistant focal onset epilepsy	15
Structure and function of language networks in temporal lobe epilepsy	15
Dynamic tractography‐based localization of spike sources and animation of spike propagations	15
Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody‐associated disease	15